Variant report

Variant	nsv882716
Chromosome Location	chr5:111848890-111894491
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:781)
CpG islands
(count:61)
Chromatin interactive
region (count:25)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:781 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr5:111885471-111885834	K562	blood:	n/a	n/a
2	ARID3A	chr5:111887108-111887506	HepG2	liver:	n/a	n/a
3	ARID3A	chr5:111883792-111884704	K562	blood:	n/a	n/a
4	ATF1	chr5:111883809-111884514	K562	blood:	n/a	n/a
5	ATF1	chr5:111887067-111887475	K562	blood:	n/a	n/a
6	ATF1	chr5:111885435-111885835	K562	blood:	n/a	n/a
7	ATF2	chr5:111859505-111859944	GM12878	blood:	n/a	n/a
8	ATF2	chr5:111858477-111858860	GM12878	blood:	n/a	n/a
9	ATF3	chr5:111883905-111884341	K562	blood:	n/a	n/a
10	BACH1	chr5:111881564-111881599	H1-hESC	embryonic stem cell:	n/a	n/a
11	BACH1	chr5:111883993-111884306	K562	blood:	n/a	n/a
12	BATF	chr5:111859586-111859905	GM12878	blood:	n/a	n/a
13	BCL11A	chr5:111858657-111858905	GM12878	blood:	n/a	n/a
14	BCL11A	chr5:111859579-111859851	GM12878	blood:	n/a	n/a
15	BCL11A	chr5:111859567-111859912	GM12878	blood:	n/a	n/a
16	BCL3	chr5:111889621-111889915	GM12878	blood:	n/a	n/a
17	BCLAF1	chr5:111859495-111859911	GM12878	blood:	n/a	n/a
18	BHLHE40	chr5:111871142-111871394	K562	blood:	n/a	n/a
19	BHLHE40	chr5:111856274-111856499	GM12878	blood:	n/a	n/a
20	BHLHE40	chr5:111849758-111850131	K562	blood:	n/a	n/a
21	BHLHE40	chr5:111886978-111887474	K562	blood:	n/a	n/a
22	BHLHE40	chr5:111887261-111887419	HepG2	liver:	n/a	n/a
23	BHLHE40	chr5:111883012-111884569	K562	blood:	n/a	n/a
24	BHLHE40	chr5:111859597-111859824	GM12878	blood:	n/a	n/a
25	BRCA1	chr5:111887168-111887529	Hela-S3	cervix:	n/a	n/a
26	CBX3	chr5:111883807-111884530	K562	blood:	n/a	n/a
27	CBX3	chr5:111883876-111884412	K562	blood:	n/a	n/a
28	CCNT2	chr5:111885389-111886039	K562	blood:	n/a	n/a
29	CCNT2	chr5:111883510-111884478	K562	blood:	n/a	n/a
30	CEBPB	chr5:111880802-111881062	A549	lung:	n/a	chr5:111880925-111880936
31	CEBPB	chr5:111851214-111851467	A549	lung:	n/a	chr5:111851295-111851306
32	CEBPB	chr5:111880780-111881054	HepG2	liver:	n/a	chr5:111880925-111880936
33	CEBPB	chr5:111851217-111851405	IMR90	lung:	n/a	chr5:111851295-111851306
34	CEBPB	chr5:111883825-111884459	K562	blood:	n/a	n/a
35	CEBPB	chr5:111851175-111851485	HepG2	liver:	n/a	chr5:111851295-111851306
36	CEBPB	chr5:111880760-111881072	K562	blood:	n/a	chr5:111880925-111880936
37	CEBPB	chr5:111865341-111865496	Hela-S3	cervix:	n/a	n/a
38	CEBPB	chr5:111851157-111851483	K562	blood:	n/a	chr5:111851295-111851306
39	CEBPB	chr5:111880784-111881051	IMR90	lung:	n/a	chr5:111880925-111880936
40	CEBPB	chr5:111883731-111884316	K562	blood:	n/a	n/a
41	CEBPD	chr5:111883757-111884404	K562	blood:	n/a	n/a
42	CEBPD	chr5:111885411-111885943	K562	blood:	n/a	n/a
43	CEBPD	chr5:111885322-111885980	K562	blood:	n/a	n/a
44	CEBPD	chr5:111883761-111884482	K562	blood:	n/a	n/a
45	CHD1	chr5:111858696-111858722	GM12878	blood:	n/a	n/a
46	CHD2	chr5:111858540-111858992	GM12878	blood:	n/a	n/a
47	CHD2	chr5:111859254-111859889	GM12878	blood:	n/a	n/a
48	CTCF	chr5:111887240-111887390	GM12875	blood:	n/a	chr5:111887307-111887325 chr5:111887309-111887330 chr5:111887308-111887324
49	CTCF	chr5:111887220-111887370	HMEC	breast:	n/a	chr5:111887307-111887325 chr5:111887309-111887330 chr5:111887308-111887324
50	CTCF	chr5:111858840-111858990	GM12867	blood:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:111869581-111869631	Hela-S3	cervix:	n/a
2	chr5:111869581-111869631	NHDF-neo	bronchial:	n/a
3	chr5:111869581-111869631	HEK293	kidney:	embryo
4	chr5:111869581-111869631	HRE	kidney:	n/a
5	chr5:111869581-111869631	SK-N-MC	brain:	n/a
6	chr5:111869581-111869631	AG09309	skin:	n/a
7	chr5:111869581-111869631	GM19239	blood:	n/a
8	chr5:111869581-111869631	HMEC	breast:	n/a
9	chr5:111869581-111869631	A549	lung:	n/a
10	chr5:111869581-111869631	IMR90	lung:	fetal
11	chr5:111869581-111869631	PANC-1	pancreas:	n/a
12	chr5:111869581-111869631	HEEpiC	esophagus:	n/a
13	chr5:111869581-111869631	SK-N-SH_RA	brain:	n/a
14	chr5:111869581-111869631	HIPEpiC	eye:	n/a
15	chr5:111869581-111869631	PrEC	prostate:	n/a
16	chr5:111869581-111869631	HRPEpiC	eye:	n/a
17	chr5:111869581-111869631	HPAEpiC	pulmonary alveolar:	n/a
18	chr5:111869581-111869631	GM12892	blood:	n/a
19	chr5:111869581-111869631	SAEC	small airway:	n/a
20	chr5:111869581-111869631	K562	blood:	n/a
21	chr5:111869581-111869631	U87	brain:	n/a
22	chr5:111869581-111869631	Caco-2	colon:	n/a
23	chr5:111869581-111869631	SK-N-SH	brain:	n/a
24	chr5:111869581-111869631	Jurkat	blood:	n/a
25	chr5:111869581-111869631	HUVEC	blood vessel:	n/a
26	chr5:111869581-111869631	AG09319	gingival:	n/a
27	chr5:111869581-111869631	Hepatocyte	liver:	n/a
28	chr5:111869581-111869631	HCF	heart:	n/a
29	chr5:111869581-111869631	BJ	skin:	n/a
30	chr5:111869581-111869631	SKMC	muscle:	n/a
31	chr5:111869581-111869631	NH-A	brain:	n/a
32	chr5:111869581-111869631	HCM	heart:	n/a
33	chr5:111869581-111869631	ovcar-3	ovarian:	n/a
34	chr5:111869581-111869631	HNPCEpiC	eye:	n/a
35	chr5:111869581-111869631	BE2_C	brain:	n/a
36	chr5:111869581-111869631	HAEpiC	amniotic membrane:	n/a
37	chr5:111869581-111869631	T-47D	breast:	n/a
38	chr5:111869581-111869631	GM12891	blood:	n/a
39	chr5:111869581-111869631	PFSK-1	brain:	n/a
40	chr5:111869581-111869631	AG04450	lung:	fetal
41	chr5:111869581-111869631	AG04449	skin:	fetal
42	chr5:111869581-111869631	HCPEpiC	choroid plexus:	n/a
43	chr5:111869581-111869631	ProgFib	skin:	n/a
44	chr5:111869581-111869631	MCF10A-Er-Src	breast:	n/a
45	chr5:111869581-111869631	AG10803	skin:	n/a
46	chr5:111869581-111869631	GM06990	blood:	n/a
47	chr5:111869581-111869631	RPTEC	kidney:	n/a
48	chr5:111869581-111869631	CMK	blood:	n/a
49	chr5:111869581-111869631	NHBE	bronchial:	n/a
50	chr5:111869581-111869631	AoSMC	blood vessel:	n/a

(count:25 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr5:111887607..111889700-chr5:111892241..111894417,2	K562	blood:
2	chr5:111886306..111888838-chr5:111889426..111891005,2	K562	blood:
3	chr3:124140032..124140554-chr5:111855676..111856423,2	MCF-7	breast:
4	chr5:111827820..111828819-chr5:111886665..111887192,2	MCF-7	breast:
5	chr5:111827723..111828709-chr5:111886769..111887504,3	MCF-7	breast:
6	chr5:111887498..111890102-chr5:112044744..112046649,2	MCF-7	breast:
7	chr5:111881836..111883481-chr5:112041986..112044748,2	K562	blood:
8	chr5:111887607..111889700-chr5:111892241..111894417,2	K562	blood:
9	chr5:111496580..111499144-chr5:111884789..111886840,2	K562	blood:
10	chr5:111886306..111888838-chr5:111889426..111891005,2	K562	blood:
11	chr5:111887102..111888171-chr5:112026844..112028152,5	MCF-7	breast:
12	chr5:111857753..111860186-chr5:111861145..111863385,2	K562	blood:
13	chr5:111886837..111887799-chr5:112092992..112093906,9	K562	blood:
14	chr5:111871115..111873160-chr5:111927827..111929771,2	K562	blood:
15	chr5:111868244..111870833-chr5:111871300..111873976,3	K562	blood:
16	chr5:111496398..111498686-chr5:111868058..111870036,2	MCF-7	breast:
17	chr5:111857753..111860186-chr5:111861145..111863385,2	K562	blood:
18	chr5:111868244..111870833-chr5:111871300..111873976,2	K562	blood:
19	chr5:111868244..111870833-chr5:111871300..111873976,3	K562	blood:
20	chr5:111886884..111887988-chr5:111940509..111941323,3	K562	blood:
21	chr2:150164278..150165118-chr5:111885955..111886738,2	MCF-7	breast:
22	chr5:111886846..111887851-chr5:112092877..112093891,4	MCF-7	breast:
23	chr5:111886856..111887404-chr5:112046425..112047135,2	MCF-7	breast:
24	chr5:111868244..111870833-chr5:111871300..111873976,2	K562	blood:
25	chr5:111884694..111888064-chr5:112042220..112044384,3	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-APC-7	chr5:111882670-111883202	NONHSAT103231

No data

Variant related genes	Relation type
ENSG00000251014	TF binding region
ENSG00000251014	CpG island
ENSG00000238363	chromatin interactions
ENSG00000224032	chromatin interactions
ENSG00000134982	chromatin interactions

Extended variants
information (count: 1894 )
Associated
traits (count: 79 )

Variant overlapped rSNPs/rCNVs (count:1894 , 50 per page) page: 1 2 3 4 5 6 7 ... 38

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs111680536	chr5:111855201-111855202	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs137916472	chr5:111855211-111855212	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs73225749	chr5:111855212-111855213	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs572063542	chr5:111855221-111855222	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs542694126	chr5:111855223-111855224	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs554273358	chr5:111855232-111855233	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs149445454	chr5:111855306-111855307	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs186022733	chr5:111855324-111855325	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs35123508	chr5:111855330-111855331	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs565066785	chr5:111855359-111855360	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs143091222	chr5:111855364-111855365	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs59860495	chr5:111855384-111855385	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs192063083	chr5:111855388-111855389	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs113924688	chr5:111855419-111855420	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs529940184	chr5:111855429-111855430	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs548923840	chr5:111855443-111855444	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs10074017	chr5:111855457-111855458	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs531805133	chr5:111855494-111855495	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs72797852	chr5:111855531-111855532	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs142743748	chr5:111855587-111855588	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs376503114	chr5:111855610-111855611	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs539282372	chr5:111855629-111855630	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs401722	chr5:111855652-111855653	Enhancers Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs572375716	chr5:111855668-111855669	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs528214302	chr5:111855671-111855672	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs73225750	chr5:111855678-111855679	Enhancers Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs546722112	chr5:111855682-111855683	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs374365540	chr5:111855698-111855699	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs536959008	chr5:111855701-111855702	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs541463368	chr5:111855736-111855737	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs528502082	chr5:111855752-111855753	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs554519695	chr5:111855768-111855769	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs568220959	chr5:111855784-111855785	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs535663674	chr5:111855786-111855787	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs575974473	chr5:111855795-111855796	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs554091005	chr5:111855822-111855823	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs557265383	chr5:111855825-111855826	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs543485844	chr5:111855846-111855847	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs558409931	chr5:111855892-111855893	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs2114999	chr5:111855913-111855914	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs574022502	chr5:111855940-111855941	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs117080207	chr5:111856000-111856001	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs184153084	chr5:111856045-111856046	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs541781183	chr5:111856068-111856069	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs562636264	chr5:111856071-111856072	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs187767902	chr5:111856090-111856091	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs531644148	chr5:111856101-111856102	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs550242255	chr5:111856161-111856162	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs565285922	chr5:111856188-111856189	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs190681490	chr5:111856241-111856242	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:79)

Disease	PMID	Source
Metanephric adenoma	20802469	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Cancer	16751803	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Breast cancer	17393978	CNVD
Cancer	21359685	CNVD
Non-small cell lung cancer	21829676	CNVD
adenomatous polyposis	22470819	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Lung cancer	18438408	CNVD
Retinoblastoma	22278416	CNVD
Bipolar disorder	18458673	CNVD
Thyroid cancer	19087340	CNVD
Breast cancer	21785460	CNVD
Squamous cell cancer	20885788	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	22521361	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	17133270	CNVD
Acute myeloid leukemia	20729466	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Acute myeloid leukemia	21251322	CNVD
lymphocytic leukemia	21291569	CNVD
Cancer	20164920	CNVD
Myelodysplastic syndrome	21251322	CNVD
abnormal development	18461090	CNVD
Colorectal cancer	16774939	CNVD
Colorectal cancer	16272173	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Multiple myeloma	17550852	CNVD
Ovarian cancer	21720365	CNVD
Neurocytoma	17123091	CNVD
Salivary gland tumor	18059337	CNVD
Myelofibrosis	22110671	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Renal cell carcinoma	19377443	CNVD
Colorectal cancer	21297112	CNVD
Glioblastoma multiforme	22286061	CNVD
Prostate cancer	16461572	CNVD

Chromatin state (count:309 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:111855200-111857000	Enhancers	Primary B cells from peripheral blood	blood
2	chr5:111855600-111856000	Enhancers	GM12878-XiMat	blood
3	chr5:111855600-111856400	Active TSS	Monocytes-CD14+_RO01746	blood
4	chr5:111855600-111859400	Enhancers	Primary B cells from cord blood	blood
5	chr5:111855800-111857600	Enhancers	Primary monocytes fromperipheralblood	blood
6	chr5:111856000-111856200	Flanking Active TSS	GM12878-XiMat	blood
7	chr5:111856200-111856400	Enhancers	GM12878-XiMat	blood
8	chr5:111856400-111856600	Flanking Active TSS	GM12878-XiMat	blood
9	chr5:111856400-111856800	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
10	chr5:111856600-111856800	Active TSS	GM12878-XiMat	blood
11	chr5:111856800-111857200	Enhancers	Monocytes-CD14+_RO01746	blood
12	chr5:111856800-111857400	Flanking Active TSS	GM12878-XiMat	blood
13	chr5:111857000-111857800	Flanking Active TSS	Primary B cells from peripheral blood	blood
14	chr5:111857200-111858400	Active TSS	Rectal Mucosa Donor 29	rectum
15	chr5:111857200-111858400	Weak transcription	Monocytes-CD14+_RO01746	blood
16	chr5:111857400-111857600	Enhancers	GM12878-XiMat	blood
17	chr5:111857600-111858000	Weak transcription	Primary monocytes fromperipheralblood	blood
18	chr5:111857600-111858200	Flanking Active TSS	GM12878-XiMat	blood
19	chr5:111857800-111859200	Enhancers	Primary B cells from peripheral blood	blood
20	chr5:111858000-111860600	Enhancers	Primary monocytes fromperipheralblood	blood
21	chr5:111858200-111858400	Enhancers	GM12878-XiMat	blood
22	chr5:111858400-111858600	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
23	chr5:111858400-111859400	Flanking Active TSS	GM12878-XiMat	blood
24	chr5:111858400-111860600	Enhancers	Monocytes-CD14+_RO01746	blood
25	chr5:111858600-111859200	Enhancers	Rectal Mucosa Donor 29	rectum
26	chr5:111858600-111859400	Enhancers	Stomach Mucosa	stomach
27	chr5:111858600-111859600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
28	chr5:111858600-111859800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
29	chr5:111858600-111859800	Enhancers	Rectal Mucosa Donor 31	rectum
30	chr5:111858600-111860200	Enhancers	Sigmoid Colon	Sigmoid Colon
31	chr5:111858600-111860600	Enhancers	Adipose Nuclei	Adipose
32	chr5:111858800-111859200	Enhancers	H1 Cell Line	embryonic stem cell
33	chr5:111859000-111859400	Enhancers	Esophagus	oesophagus
34	chr5:111859000-111859400	Enhancers	Small Intestine	intestine
35	chr5:111859000-111860200	Enhancers	Duodenum Mucosa	Duodenum
36	chr5:111859200-111859400	Flanking Active TSS	Primary B cells from peripheral blood	blood
37	chr5:111859200-111860200	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
38	chr5:111859400-111859800	Enhancers	Primary B cells from peripheral blood	blood
39	chr5:111859400-111860000	Enhancers	GM12878-XiMat	blood
40	chr5:111859400-111860400	Flanking Active TSS	Primary B cells from cord blood	blood
41	chr5:111859600-111860400	Enhancers	Spleen	Spleen
42	chr5:111859800-111860200	Active TSS	Primary Natural Killer cells fromperipheralblood	blood
43	chr5:111859800-111861000	Flanking Active TSS	Primary B cells from peripheral blood	blood
44	chr5:111860000-111861000	Flanking Active TSS	GM12878-XiMat	blood
45	chr5:111860200-111861200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
46	chr5:111860400-111861600	Enhancers	Primary B cells from cord blood	blood
47	chr5:111860600-111863400	Weak transcription	Adipose Nuclei	Adipose
48	chr5:111861000-111861200	Enhancers	Small Intestine	intestine
49	chr5:111861000-111861600	Enhancers	GM12878-XiMat	blood
50	chr5:111861000-111863400	Enhancers	Primary B cells from peripheral blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links